Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials

被引：0
|
作者：
Zhang, Chenyue [1 ]
Wang, Haiyong [2 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Integrated Therapy, Shanghai, Peoples R China
[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Internal Med Oncol, Jinan, Peoples R China
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2021年 / 6卷 / 01期
关键词：
D O I：
10.1038/s41392-021-00557-9
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：3
相关论文
共 31 条
  • [31] Improving ethnic and racial diversity in biomarker-driven clinical trials: A proof of concept with the BASECAMP-1 master prescreening study of patients with high-risk solid tumors with human leukocyte antigen-A*02 (HLA-A*02) loss of heterozygosity (LOH)
    Smith, Caleb Joshua
    Simeone, Diane M.
    Grierson, Patrick
    Kirtane, Kedar
    Morelli, Maria Pia
    Patel, Sandip Pravin
    Ulrickson, Matthew L.
    Dahiya, Saurabh
    Park, Jong Chul
    Specht, Jennifer M.
    Fakih, Marwan
    Liechty, Kirstin B.
    Tebbets, Jessica
    Welch, John Sutton
    Go, William Y.
    Maloney, David G.
    Maus, Marcela Valderrama
    Ng, Eric Wai-Choi
    Hecht, J. Randolph
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
1234